drugset / Trial / NCT05204836

Altering Bone Microarchitecture and Mechanics by Off-label Pharmaceutical Intervention Following an Acute Knee Injury

NCT05204836

Phase 1 Terminated 4 enrolled University of Calgary
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to assess if a zoledronic acid injection can alter the trajectory of joint degeneration following an acute anterior cruciate ligament (ACL) injury.

Timeline

Start
2023-05-16
Primary completion
2025-07-03
Completion
2025-07-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Zoledronic acid Other / unclassified 5 mg Intravenous

Indications